Cytokeratin expression in lichen amyloidosus and macular amyloidosis

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 3, 2004, Pages 305-309

  Apaydin, R ^a   Gurbuz Y ^a   Bayramgurler D ^a   Muezzinoglu B ^a   Bilen, N ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Cytokeratin; Lichen amyloidosus; Macular amyloidosis

Indexed keywords

AMYLOID; CYTOKERATIN; CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 8; FORMALDEHYDE; MONOCLONAL ANTIBODY; PARAFFIN;

ACIDITY; ADULT; AGED; AMYLOIDOSIS; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; EPIDERMIS CELL; FEMALE; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LICHEN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; TISSUE FIXATION; TISSUE SECTION;

ADULT; AGED; AMYLOID; AMYLOIDOSIS; BIOPSY, NEEDLE; COHORT STUDIES; CULTURE TECHNIQUES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MIDDLE AGED; PROGNOSIS; SERUM AMYLOID A PROTEIN; SEVERITY OF ILLNESS INDEX; SKIN DISEASES;

EID: 2442436900     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00905.x     Document Type: Article

References (23)

1. Looi LM. Primary localized cutaneous amyloidosis in Malaysians. Australas J Dermatol 1991; 32: 39-44.
2. Breatnach SM. The cutaneous amyloidoses: pathogenesis and therapy. Arch Dermatol 1985; 121: 470-475.
3. Black MM. The role of the epidermis in the histopathogenesis of lichen amyloidosus: histochemical correlations. Br J Dermatol 1971; 85: 524-530.
4. Maeda H, Ohta S, Saito Y et al. Epidermal origin of the amyloid in localized cutaneous amyloidosis. Br J Dermatol 1982; 106: 345-351.
5. Dahlback K, Sakai L. Immunohistochemical studies on fibrillin in amyloidosis, lichen ruber planus and porphyria. Acta Derm Venereol 1990; 70: 275-280.
6. Ishii M, Kobayashi H, Chanoki M et al. Possible formation of cutaneous amyloid from degenerative collagen fibers: ultrastructural collagen changes and the immunoreactivity of cutaneous amyloidosis employing anti-type I, III, IV, V collagen antibodies. Acta Derm Venereol 1990; 70: 378-384.
7. Brownstein M, Hashimoto K. Macular amyloidosis. Arch Dermatol 1972; 106: 50-57.
8. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
9. Irvine AD, McLean WHI. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999; 140: 815-828.
10. Steinert PM. Structure, function, and dynamics of keratin intermediate filaments. J Invest Dermatol 1993; 100: 729-734.
11. Hashimoto K, Ito K, Taniguchi Y et al. Keratin in cutaneous amyloidoses. Clin Dermatol 1990; 2: 55-65.
12. Kobayashi H, Hashimoto K. Amyloidogenesis in organ-limited cutaneous amyloidosis: an antigenic identity between epidermal keratin and skin amyloid. J Invest Dermatol 1983; 80: 66-72.
13. Kumakiri M, Hashimoto K. Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration. J Invest Dermatol 1979; 73: 150-152.
14. Ito K, Hashimoto K. Antikeratin autoantibodies in the amyloid deposits of lichen amyloidosus and macular amyloidosis. Arch Dermatol Res 1989; 281: 377-382.
15. Chang YT, Wong CK, Chow KC, Tsai CH. Apoptosis in primary cutaneous amyloidosis. Br J Dermatol 1999; 140: 210-215.
16. Chang YT, Liu HN, Wong CK et al. Detection of Epstein-Barr virus in primary cutaneous amyloidosis. Br J Dermatol 1997; 136: 823-826.
17. Apaydin R, Bilen N, Bayramgürler D et al. Lichen amyloidosis, ankylosing spondylitis and autoimmune thyroiditis: coincidence or association? J Eur Acad Dermatol Venereol 2000; 14: 135-137.
18. Noren P, Westermark P, Cornwell GG III, Murdoch W. Immunofluorescence and histochemical studies of localized cutaneous amyloidosis. Br J Dermatol 1983; 108: 277-285.
19. Ishii M, Asai Y, Hamada T. Evaluation of cutaneous amyloid employing anti-keratin antibodies and the immunoperoxidase technique (PAP method). Acta Derm Venereol 1984; 64: 281-285.
20. Yoneda K, Watanabe H, Yanagihara M, Mori S. Immunohistochemical staining properties of amyloids with antikeratin antibodies using formalin-fixed, paraffin-embedded sections. J Cutan Pathol 1989; 16: 133-136.
21. Ortiz-Romero PL, Ballestin-Carcavilla C, Lopez-Estebaranz JL, Iglesias-Diez L. Clinicopathologic and immunohistochemical studies on lichen amyloidosis and macular amyloidosis. Arch Dermatol 1994; 130: 1559-1560.
22. Huilgol SC, Ramnarain N, Carrington P et al. Cytokeratins in primary cutaneous amyloidosis. Australas J Dermatol 1998; 39: 81-85.
23. Inoue K, Takahashi M, Hamamoto Y et al. An immunohistochemical study of cytokeratins in skin-limited amyloidosis. Amyloid 2000, 7: 259-265.